In the last trading session, 7.81 million shares of the Merck & Co Inc (NYSE:MRK) were traded, and its beta was 0.41. Most recently the company’s share price was $126.94, and it changed around $1.16 or 0.92% from the last close, which brings the market valuation of the company to $321.49B. MRK currently trades at a discount to its 52-week high of $133.10, offering almost -4.85% off that amount. The share price’s 52-week low was $99.14, which indicates that the current value has risen by an impressive 21.9% since then. We note from Merck & Co Inc’s average daily trading volume that its 3-month average coming to 8.31 million.
Merck & Co Inc stock received a consensus recommendation rating of Hold, based on a mean score of 1.55. If we narrow it down even further, the data shows that 0 out of 21 analysts rate the stock as a Sell; another 4 rate it as Overweight. Among the rest, 10 recommended MRK as a Hold, whereas 7 deemed it a Buy, and 0 rated it as Underweight. Merck & Co Inc is expected to report earnings per share of $Marathon Oil Corporation for the current quarter.
Merck & Co Inc (NYSE:MRK) trade information
Instantly MRK has showed a green trend with a performance of 0.92% at the end of last trading. The performance over the last five days has remained in the green territory. The company’s shares are currently up 16.44% year-to-date, but still up 0.59% over the last five days. On the other hand, Merck & Co Inc (NYSE:MRK) is 2.69% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $118.74, which translates to bulls needing to decrease their stock price by -6.91% from its current value. Analyst projections state that MRK is forecast to be at a low of $80 and a high of $294.
Merck & Co Inc (MRK) estimates and forecasts
Merck & Co Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 26.40 percent over the past six months and at a 468.87% annual growth rate that is well above the industry average of 3.70%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -42.70%. Merck & Co Inc earnings are expected to increase by 466.79% in 2024, but the outlook is positive 67.38% per year for the next five years.
MRK Dividends
Merck & Co Inc’s next quarterly earnings report is expected to be released in May. The annual dividend yield of the stock is 2.36 percent and its annual dividend per share was 3.00. It is important to note, however, that the 2.36% dividend yield ratio should be regarded as a guide only, as many other factors should be taken into consideration before making any investment decision.
